Search research articles
Contact Us
Filters
Showing results (31-40 of 170) with videos related to
Page
of 17
Sort By:
Dementia and Geriatric Cognitive Disorders
|
May 15, 2001
Reduced expression of amyloid precursor protein, presenilin-1 and rab3a in cortical brain regions in Alzheimer's disease
P Davidsson, N Bogdanovic, L Lannfelt, et al.
Biological Psychiatry
|
January 15, 1995
Schizophrenia and APP gene mutations
E Jönsson, C Forsell, L Lannfelt, et al.
Archives of Neurology
|
December 1, 1994
A large Swedish family with Alzheimer's disease with a codon 670/671 amyloid precursor protein mutation. A clinical and genealogical investigation
K Axelman, H Basun, B Winblad, et al.
Dementia and Geriatric Cognitive Disorders
|
August 19, 2007
Reduction of phosphorylated tau during memantine treatment of Alzheimer's disease
M Degerman Gunnarsson, L Kilander, H Basun, et al.
Journal of Neurochemistry
|
February 26, 1999
Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670/671 mutation
A Marutle, U Warpman, N Bogdanovic, et al.
Lancet (London, England)
|
October 7, 1995
Apolipoprotein E-epsilon 4 gene dose
E Corder, H Basun, L Lannfelt, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
August 15, 1989
ELISA for measuring porphobilinogen deaminase in human erythrocytes
L Lannfelt, L Wetterberg, L Lilius, et al.
FEBS Letters
|
October 7, 1996
Quantification of presenilin-1 mRNA in Alzheimer's disease brains
J A Johnston, S Froelich, L Lannfelt, et al.
Archives of Gerontology and Geriatrics
|
May 1, 1996
Apolipoprotein E epsilon4 allele, skin vessel reactivity and vascular risk factors in Alzheimer's disease
A Algotsson, A Nordberg, L Lannfelt, et al.
Journal of Internal Medicine
|
April 1, 1992
Frequency of low erythrocyte porphobilinogen deaminase activity in Finland
P Mustajoki, R Kauppinen, L Lannfelt, et al.
Page
of 17
Search research articles
Search
Showing results (31-40 of 170) with videos related to
Sort By:
Page
of 17
Dementia and Geriatric Cognitive Disorders
|
May 15, 2001
Reduced expression of amyloid precursor protein, presenilin-1 and rab3a in cortical brain regions in Alzheimer's disease
P Davidsson, N Bogdanovic, L Lannfelt, et al.
Biological Psychiatry
|
January 15, 1995
Schizophrenia and APP gene mutations
E Jönsson, C Forsell, L Lannfelt, et al.
Archives of Neurology
|
December 1, 1994
A large Swedish family with Alzheimer's disease with a codon 670/671 amyloid precursor protein mutation. A clinical and genealogical investigation
K Axelman, H Basun, B Winblad, et al.
Dementia and Geriatric Cognitive Disorders
|
August 19, 2007
Reduction of phosphorylated tau during memantine treatment of Alzheimer's disease
M Degerman Gunnarsson, L Kilander, H Basun, et al.
Journal of Neurochemistry
|
February 26, 1999
Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670/671 mutation
A Marutle, U Warpman, N Bogdanovic, et al.
Lancet (London, England)
|
October 7, 1995
Apolipoprotein E-epsilon 4 gene dose
E Corder, H Basun, L Lannfelt, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
August 15, 1989
ELISA for measuring porphobilinogen deaminase in human erythrocytes
L Lannfelt, L Wetterberg, L Lilius, et al.
FEBS Letters
|
October 7, 1996
Quantification of presenilin-1 mRNA in Alzheimer's disease brains
J A Johnston, S Froelich, L Lannfelt, et al.
Archives of Gerontology and Geriatrics
|
May 1, 1996
Apolipoprotein E epsilon4 allele, skin vessel reactivity and vascular risk factors in Alzheimer's disease
A Algotsson, A Nordberg, L Lannfelt, et al.
Journal of Internal Medicine
|
April 1, 1992
Frequency of low erythrocyte porphobilinogen deaminase activity in Finland
P Mustajoki, R Kauppinen, L Lannfelt, et al.
Page
of 17